SMSPHARMA.NSSMSPHARMA.NSNSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank93
3Y CAGR+20.5%
5Y CAGR+4.5%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+20.5%/yr
vs -1.0%/yr prior
5Y CAGR
+4.5%/yr
Recent acceleration
Acceleration
+21.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.26B+55.7%
2025$1.45B-31.3%
2024$2.11B+63.6%
2023$1.29B-28.9%
2022$1.81B+0.0%
2021$1.81B+42.5%
2020$1.27B-5.2%
2019$1.34B-1.4%
2018$1.36B-42.8%
2017$2.38B-